Contract facts
FederalMHS GENESIS SUPPORT is a federal award for Defense Health Agency held by Leidos, Inc. Estimated value $572.1M ($304.4M obligated). Current period of performance ends Jul 28, 2026. Place of performance: RESTON, VA.
Recompete timing
PublicCurrent PoP ended Jul 28, 2026 (23 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordLeidos, Inc — $7.8B obligated across 10,908 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT003825F0007?
HT003825F0007 (MHS genesis support) is a Defense Health Agency award with an estimated value of $572.1M, currently held by Leidos, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT0038-25-F-0007?
HT0038-25-F-0007 is the dashed form of PIID HT003825F0007 (MHS genesis support), held by Leidos, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT003825F0007?
Defense Health Agency awarded HT003825F0007 to Leidos, Inc.
Who is the incumbent on HT003825F0007?
Leidos, Inc is the incumbent with $7.8B across 10908 related awards in SCOUT’s public footprint. The current period of performance ends Jul 28, 2026.
When does Leidos, Inc’s HT003825F0007 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 28, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.